Demo

2761 Articles Matching "therapy"

Amazon Stopped Selling Books Promoting Conversion Therapy, And Some People Are Mad

Jul 22, 2019 , Forbes
"Now the pitchfork and torch-wielding witch-hunt has come for our freedom to obtain and read books others believe are offensive," wrote one conservative critic of Amazon's decision. "How long until the most widely read book in the world is banned because it takes a dim view of...
Read more

UnitedHealth Reverses Course, Approves Coverage For $2.1 Million Gene Therapy For Family Racing Against Clock

Jul 20, 2019 , Kaiser Health News
Lauren Sullivan had been trying to appeal UnitedHealth's initial refusal of the drug for her 21-month-old daughter, Daryn. The girl was running out of time to receive the treatment before her second birthday in October, when the drug has to be administered. The company also approved claims for three other patients. In other news, UnitedHealth beats expectations for the quarter, prompting company to boost earnings...
Read more

First Major Trial Of VR Therapy For Serious Mental Health Conditions Launches

Jul 16, 2019 , Forbes
Healthtech startup Oxford VR has teamed up with GameChange to test its VR mental health therapy program and advance its roll out across the National Health...
Read more

Training A Generation Of Gun Safety Advocates: Johns Hopkins Holds Intensive Course For High Schoolers From Around The Country

Jul 13, 2019 , Kaiser Health News
Inspired by the Parkland students who started a global movement after the mass shooting at their high school, Daniel Webster, director of the Johns Hopkins Center for Gun Policy and Research, said he wanted to tap into that activist base and help more teenagers become advocates. Public health news focuses on childhood malnutrition, breastfeeding, a new talc trial, caregiving, stillbirths, therapy cows and healthy hearts, as...
Read more

Karyopharm Therapeutics gets FDA OK for Xpovio

Jul 12, 2019 , Drug Store News - Retail
Karyopharm Therapeutics' Xpovio provides a treatment option for patients with multiple myeloma that has no available therapy. Read More...
Read more
Banner Health Children

Should You Try Allergen Immunotherapy?

Jul 10, 2019 , MedicineNet
Title: Should You Try Allergen Immunotherapy?Category: Health NewsCreated: 7/9/2019 12:00:00 AMLast Editorial Review: 7/9/2019 12:00:00...
Read more

Prostate Cancer Treatment Linked to Dementia Risk

Jul 09, 2019 , WebMD
In total, 13% of men who had received the therapy went on to develop Alzheimer's disease over eight years of follow-up, compared to 9%  who hadn't gotten the treatment, the study...
Read more

Custom menopause hormones have unpredictable ingredient mix

Jul 06, 2019 , Reuters
(Reuters Health) - Women who fill prescriptions for custom-blended hormone therapy may get capsules or creams that don't contain the correct amount of medicine, a recent study suggests....
Read more

Breastfeeding relaxation therapy for mothers helps babies eat more

Jul 05, 2019 , Reuters
(Reuters Health) - Mothers who get breastfeeding support that includes relaxation therapy may feel less stressed and have babies who eat and sleep more than women who don't get this extra help, a small experiment suggests....
Read more

‘Closer To A Cure’: For First Time, Researchers Eliminate HIV In Some Mice Using CRISPR, Virus Suppression Drug

Jul 03, 2019 , Kaiser Health News
Current treatment of HIV using antiretroviral therapy requires lifelong use to suppress the disease. The scientists from Temple University and the University of Nebraska Medical Center were able to eliminate the virus in nine of 23 mice, according to a study published Tuesday in Nature Communications. "The possibility exists that HIV can be cured," said Howard Gendelman, author of the...
Read more

Risk of dementia rises with prostate cancer hormone-blocking therapy

Jul 03, 2019 , Reuters
Prostate cancer patients who received hormone-lowering therapy were at higher risk of developing dementia and Alzheimer's disease later on than men who didn't get this treatment, a large U.S. study finds....
Read more
A demo

Bluebird CEO defends $1.8 million gene therapy price — 'It's really thinking about it differently'

Jun 15, 2019 , CNBC Health
Bluebird Bio's $1.8 million gene therapy, Zynteglo, is the second most expensive drug in the world behind Novartis' $2.1 million gene therapy for spinal muscular...
Read more

Enanta's lung infection therapy succeeds in mid-stage trial

Jun 15, 2019 , Reuters
Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study....
Read more

Bluebird prices gene therapy at 1.58 million euros over 5 years

Jun 15, 2019 , Reuters
Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe this month to treat a rare genetic blood disorder....
Read more

Immune Therapy A Great Tool, But Limitations Exist

Jun 14, 2019 , WebMD
Immune Therapy A Great Tool, But Limitations...
Read more

Chemoimmunotherapy Regimen Approved to Treat DLBCL

Jun 13, 2019 , MedicineNet
Title: Chemoimmunotherapy Regimen Approved to Treat DLBCLCategory: Health NewsCreated: 6/11/2019 12:00:00 AMLast Editorial Review: 6/12/2019 12:00:00...
Read more

Study: Combination of self-monitoring blood glucose device & DTx improve patient outcomes

Jun 13, 2019 , Mobile Health News
At the 79th Annual Scientific Sessions of the American Diabetes Association in San Francisco, pharma giant Roche and India-based digital therapeutics company Wellthy Therapeutics presented real world data of improved diabetes care outcomes in a South Asian population when patients followed prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-monitoring blood glucose device and a clinically validated digital therapeutic...
Read more

Experimental drug delays type 1 diabetes onset in mid-stage trial

Jun 10, 2019 , Reuters
(Reuters Health) - In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday....
Read more

Vertex Pharmaceuticals expands into Duchenne gene therapy with new deals

Jun 07, 2019 , Reuters
Vertex Pharmaceuticals Inc said ?i=43059c3bf0e37541&u=urn:newsml::20190606:nBw4wRKsa on Thursday it would acquire privately held Exonics Therapeutics for an upfront payment of $245 million and potential milestone payments of up to $750 million....
Read more

FDA Issues Clearance For The ReStore™ Exo-Suit, The First Soft Robotic System For Stroke Therapy

Jun 06, 2019 , NewsLine - Healthcare Professionals
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced today that the U.S. Food and Drug Administration ("FDA") has cleared the Company's ReStore soft exo-suit system for sale to reha......
Read more